Europe — EMA
Ketovision (Ketorolac Trometamol)
GNH USA supplies Ketovision (Ketorolac Trometamol), a nonsteroidal anti‑inflammatory eye drop for post‑operative ocular inflammation and pain.
Request sourcing
What is Ketorolac Trometamol?
Ketorolac Trometamol, the active ingredient in Ketovision, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an ocular solution (eye drops) for ocular use. It treats post‑operative inflammation and pain following eye surgery and other ocular inflammatory conditions.
GNH USA supplies Ketovision as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.
What is Ketorolac Trometamol used for?
Ketovision, a ketorolac‑based ophthalmic NSAID, is used to manage ocular inflammation and pain.
- Post‑operative ocular inflammation: reduces swelling and discomfort after eye surgery. - Post‑operative ocular pain: alleviates pain following ocular procedures. - Acute anterior uveitis: helps control inflammation and pain in the anterior segment of the eye.
What are the side effects of Ketorolac Trometamol?
Ketovision may cause local ocular reactions and, rarely, systemic complications.
Common Side Effects: - Transient eye irritation. - Blurred vision. - Conjunctival redness.
Serious or Rare Side Effects: - Corneal ulceration. - Severe allergic reaction (anaphylaxis). - Increased intraocular pressure.
What precautions apply to Ketorolac Trometamol?
When prescribing Ketovision, consider the following safety measures.
- Allergy assessment: avoid use in patients with known hypersensitivity to ketorolac or other NSAIDs. - Corneal disease: use with caution in patients with compromised corneal integrity. - Pregnancy: safety not established; avoid unless clearly needed. - Concurrent ocular infection: assess risk before use. - Store at room temperature: keep in original container, protect from light and moisture.
What does Ketorolac Trometamol interact with?
Ketovision can interact with other ocular or systemic agents; monitor patients accordingly.
Major Interactions (Avoid): - Systemic NSAIDs: increased risk of systemic adverse effects. - Anticoagulants: potential for enhanced bleeding. - Corticosteroid eye drops: may reduce anti‑inflammatory efficacy.
Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: possible additive ocular irritation. - Topical anesthetics: monitor for delayed healing.



